
zzso is considered the primary risk factor for cardiovascular zzso An estimated 200 million prescriptions are issued per year for statins to treat zzso zzso statins have additional beneficial effects independent of their effects on zzso Recent studies have shown that statins reduce zzso via multiple zzso including zzso zzso zzso and reducing the zzso expression of the zzso protein tissue zzso Many of the zzso effects of statins are attributed to zzso zzso of zzso and effects on other zzso signaling molecules such as zzso and zzso These zzso activities of statins likely contribute to the ability of statins to reduce the zzso of cardiovascular zzso 

